Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

A Sureda, C Canals, R Arranz, D Caballero, JM Ribera, M Brune, J Passweg, R Martino, D Valcárcel, J Besalduch, R Duarte, A León, MJ Pascual, A García-Noblejas, Corral L López, B Xicoy, J Sierra, N. Schmitz

Research output: Contribution to journalArticleResearch

Original languageItalian
Pages (from-to)310-317
Issue number2
Publication statusPublished - 1 Feb 2012

Cite this